Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction

As a new class of antitumor drugs, immune checkpoint inhibitors (ICIs) have shown remarkable efficacy toward the treatment of various malignant tumors. By virtue of their targets and mechanisms of action, ICIs can cause autoimmune and inflammatory effects, termed as immune‐related adverse events (ir...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thorac Cancer
Main Authors: Duan, Lian, Wang, Linjie, Wang, Hanping, Si, Xiaoyan, Zhang, Li, Liu, Xiaowei, Li, Yue, Guo, Xiaoxiao, Zhou, Jiaxin, Zhu, Huijuan
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons Australia, Ltd 2020
Teme:
Clinical Guideline
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113039/
https://ncbi.nlm.nih.gov/pubmed/32043816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13347
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki